nanoComposix will be exhibiting at nanoDDS, September 15-17, 2023 at Kresge Auditorium, Massachusetts Institute of Technology, Boston.

The Nanomedicine and Drug Delivery Symposium is the key annual event for researchers developing next-generation delivery vehicles — targeted, responsive, biodegradable nanomaterials to make diagnostics more sensitive and drugs more effective.

In January 2003 Dr. Alexander Kabanov and Dr. Kazunori Kataoka organized the first nanomedicine meeting in the United States – The Nanomedicine and Drug Delivery Symposium (nanoDDS). Since then nanoDDS has been held annually in different locations across North America. Over the years it has attracted over 3,000 participants from 30 different countries and become one of the most authoritative forums in its field. Each year the meeting comes to a different University campus, thereby promoting knowledge and becoming a major world-class scientific event for its students and scholars. The objectives of nanoDDS are to 1) discuss groundbreaking discoveries and developments in nanomedicine and drug delivery; 2) highlight clinical developments and opportunities for advancing nanomedicine technology to the marketplace; and 3) engage and educate students, postdoctoral trainees and scientists from the local university and all over the world.

Fortis Life Sciences offers reagents, tools, materials, and custom services for the biopharma industry, with the aim to offer a best-in-class customer experience. Through our nanoComposix brand, we provide precisely engineered and highly characterised nanomaterials to a global customer base.